Bm Kali Sulph Tablet
NDC Package 85816-1007-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Bm Kali Sulph (kali sulphuricum) tablets is temporarily boost cellular nutrition, satisfy mineral imbalances in the body, and stimulate the body's natural healing process. This formulation utilizes a tablet delivery system. Marketed by Bm Private Limited, this product is identified by NDC 85816-1007.

Identification & Billing

NDC Package Code
85816-1007-2
Package Description
500000 mg in 1 JAR
Product Code
11-Digit Billing Format
85816100702

Clinical Specifications

Proprietary Name
Bm Kali Sulph
Non-Proprietary Name
Kali Sulphuricum
Substance Name
Potassium Sulfate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Temporarily boost cellular nutrition, satisfy mineral imbalances in the body, and stimulate the body's natural healing process

Regulatory & Marketing

Labeler Name
Bm Private Limited
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
01-01-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (85816-1007). Click a package code to view its specific billing and regulatory data.

30000 mg in 1 BOTTLE, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85816-1007-2 identifies a specific commercial package of 500000 mg in 1 jar of Bm Kali Sulph, a human over the counter drug labeled by Bm Private Limited. This tablet is formulated for oral use and contains potassium sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bm Private Limited on January 01, 2015. The current certification is valid through December 31, 2026.

How is this Bm Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85816100702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
85816-1007-2
11-Digit CMS (5-4-2)
85816-1007-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.